ANDA 87631, held by Vangard. Imipramine Hydrochloride.
As of Nov 16, 2026, ANDA 87631 (Imipramine Hydrochloride), held by Vangard, was first approved by FDA on Jan 4, 1982, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 4, 1982 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Imipramine Hydrochloride50MG ยท tablet;oral | Imipramine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters